Click it and Unblock the Notifications
Just In
Don't Miss
-
On This Day in IPL: CSK Played their First Match at Chepauk, Dhoni scored first 20th Over Six -
Rs 2.20/Share Dividend Declared: 84-Yrs Old Small Cap Tata Co Reports 7.7% Rise In Net -
Rohit Saraf, Pashmina Roshan Starrer Ishq Vishk Rebound Delayed Again Despite Being Fully Ready -
Anant Ambani-Radhika Merchant's Wedding Function Details Are Out, Check out Ambani Bahu-To-Be's Chic Fashion! -
Meet Naima Khatoon, First Vice Chancellor of AMU, Know Her Background and Education Qualification -
Xiaomi Robot Vacuum Cleaner S10, Handheld Garment Steamer, and Redmi Buds 5A Launched in India -
Nissan Magnite Achieves 1 Lakh Unit Sales Milestone: Consistency Helps -
Kurnool's Hidden Gems: A Guide To Exploring India's Lesser-Known Treasures
Soon, spray to treat premature ejaculation
London, Aug 8 (ANI): An investigational new drug PSD502 has been found highly effective in treating primary premature ejaculation (PE).
The British-designed remedy can make afflicted men's lovemaking last five times longer.
However, even with a five-fold increase, it's only up to an average of three minutes, 18 seconds, reports News of the World.
The remedy is sprayed on the penis five minutes before sexual intercourse, with the ingredients lidocaine and prilocaine preventing over-sensitivity without causing numbness.
Two studies into the drug, known for now only as PSD502, involved 539 men from Europe, the USA and Canada - who had to use stopwatches to time their performances.
On average the men in the three-month study, who all suffered from the quick-trigger syndrome, lasted much longer.
Even those given a placebo spray - not containing the drug - also noted a 1.6-fold increase in staying power, upping their average to 56 seconds. Only three percent said the spray made them lose their erection. (ANI)
